CAVE CREEK, AZ — (Marketwired) — 07/25/17 — Endexx Corporation (OTC PINK: EDXC), a provider of innovative phyto-nutrient-based food and nutritional products, announced today it will be attending the SuperZoo Show held on July 25-27, 2017 at the Mandalay Bay Convention Center in Las Vegas.
Endexx will be exhibiting at booth #2812 and showcasing its Phyto-Bites® line of products, its cannabidiol CBD) infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation.
Todd Davis, CEO of Endexx said, “SuperZoo 2017 is North America–s premier show for the pet industry with over 5000 industry buyers present and we are confident that the booming pet industry will respond with the enthusiasm that we have received from our customers. PhytoBites is uniquely positioned to offer customers the highest therapeutic value product for their pets.”
For additional information on Phyto-Bites®, please visit .
Endexx provides innovative inventory management and technology solutions. Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. Phyto-Bites®, is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The company also has two technology products and services that launched in 2014 — the M3hub and the Autospense. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and an “End of Sale” technology integration. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to eventual federal mandates. The Autospense is a commercial grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Autospense increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. Websites include: , , .
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company–s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company–s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company–s periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
For further investor and media information, contact:
Endexx Corporation
Todd Davis
Chairman & CEO
480-595-6900
IRTH Communications
866-976-4784
You must be logged in to post a comment Login